BioWorld

April 29, 2008

Targeted Genetics' Gene Therapy Shown to Improve Vision

Data reported from two separate studies showed that gene therapy improved the vision of some patients with a rare inherited degenerative eye disease that leads to blindness by age 30. (BioWorld Today) Read More

Quaker Aiming to Invest $420M Fund in Mid-Atlantic Companies

Allergy Kinase May Find Second Home in HIV Targeting Programs

Nuon Raises $27M to Move Tranilast Through Phase II

Other News To Note

Clinic Roundup

Appointments And Advancements

Today's news in brief

BioWorld

BioWorld briefs for June 3, 2026.

ASCO 2026: A revolution in pancreatic cancer

BioWorld

At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...

News in brief

BioWorld Asia

BioWorld Asia briefs for June 2, 2026

EASL 2026: Emerging liver disease targets to watch

BioWorld

At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...

Bispecific antibodies with heavy chain in green and pink, light chain in blue and yellow

ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out

BioWorld

Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...